• Oluwakemi Alonge MPH, CPH

  • Epidemiologist I, M.S.


    • MCRI - MCRI-Clin Epidem and Pop Hlth
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449

Education

2012 to 2016:
BSc., Microbiology, Obafemi Awolowo University, Ile-Ife, Nigeria
2018 to 2020:
MPH, Epidemiology, Texas A&M University, School of Public Health, College Station, Texas

Work Experience

2021 to Present:
Epidemiologist, Marshfield Clinic Research Institute, Marshfield, WI
2020 to 2021:
Epidemiologist II, Texas Department of State Health Services, Austin, TX
2019 to 2019:
Public Health Graduate Intern, Texas Department of State Health Services, San Antonio, TX
2016 to 2017:
Adverse Drug Reaction (ADR) Surveillance Graduate Intern, National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria
2015 to 2015:
Medical Laboratory Assistant, Nigerian National Petroleum Corporation (NNPC) Medical Services, Portharcourt, Nigeria

Statement

Oluwakemi (Kemi) is an epidemiologist and project manager on several epidemiologic studies within the research program. She provides data management and analytic support to study investigators, coordination of research teams, study planning and implementation, protocol development, scientific presentations, manuscript preparation and publication.

After receiving her MPH from Texas A&M University in 2020, Ms. Alonge worked as an epidemiologist for the Texas Department of State Health Services. She served as a subject matter expert on tuberculosis contact investigation and was responsible for managing and analyzing data in the Texas tb contact investigation database. She also performed quality assurance of contact investigation data being reported into the state’s tuberculosis surveillance system.


Select Publications

  • Alonge, OD, Marin, M, Hickman, CJ, Sowers, SB, Chen, M, Hao, L,...Nguyen, Huong [including McClure, DL.] Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses among Adults with Three Doses of Measles-Mumps-Rubella Vaccine. [published online ahead of print 2024 January 3]. Open Forum Infectious Diseases. 11(1). doi: https://doi.org/10.1093/ofid/ofad700.
  • Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L,...Nguyen HQ [including McClure DL.] Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine. Open Forum Infect Dis.. 2024 January;11(1):ofad700. doi: 10.1093/ofid/ofad700. PMCID: PMC10783245.
    PubMed ID: 38213634